Suchergebnisse - "Yeh, Kun-Huei"

PubPharm (11)

1

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

enthalten in: The New England journal of medicine | 2023

von Fakih, M. | Salvatore, L. | Esaki, T. | +16

2

A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue

enthalten in: Haematologica | 2020

von Tsai, H. | Tai, J. | Chen, L. | +27

3

A nationwide survey of fatigue in cancer patients in Taiwan : an unmet need

enthalten in: Japanese journal of clinical oncology | 2020

von Rau, K. | Shun, S. | Chiou, T. | +7

4

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2) : 2-year update data

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2020

von Chen, L. | Satoh, T. | Ryu, M. | +22

CommentIn: Gastric Cancer. 2020 Nov;23(6):1107-1108. - PMID 32424650

5

Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer : a randomized Phase III study

enthalten in: Future oncology (London, England) | 2018

von Li, J. | Xu, R. | Qin, S. | +16

ErratumIn: Future Oncol. 2019 Feb;15(4):451. - PMID 30672339

6

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Javle, M. | Lowery, M. | Shroff, R. | +26

CommentIn: Hepatology. 2018 Dec;68(6):2428-2430. - PMID 29704257

7

Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer : The Phase 2 APEC Study

enthalten in: Clinical colorectal cancer | 2017

von Cheng, A. | Cornelio, G. | Shen, L. | +26

8

Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan : a multicenter prospective Phase II trial

enthalten in: Japanese journal of clinical oncology | 2015

von Hsieh, J. | Hsu, C. | Ng, S. | +10

9

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations : TyTAN--a randomized, phase III study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Satoh, T. | Xu, R. | Chung, H. | +16

10

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Chao, Y. | Hsieh, J. | Yeh, H. | +8